A look into the future: the role of PSMA beyond prostate cancer
Authors:
Open Access
- 11 August 2023
- journal article
- editorial
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 51 (1) , 278-280
Abstract
No abstract availableThis publication has 25 references indexed in Scilit:
- Visual and volumetric parameters by 18F-FDG-PET/CT: a head to head comparison for the prediction of outcome in patients with multiple myelomaAnnals of Hematology, 2019
- Total metabolic tumor volume by 18F-FDG PET/CT for the prediction of outcome in patients with non-small cell lung cancerAnnals of Nuclear Medicine, 2019
- Prostate-specific Membrane Antigen Heterogeneity and DNA Repair Defects in Prostate CancerEuropean Urology, 2019
- Vertebral Myeloma Mimicking Prostatic Carcinoma Metastasis in 68Ga-PSMA PET/CTClinical Nuclear Medicine, 2017
- Image of the MonthClinical Nuclear Medicine, 2017
- 68Ga-PSMA PET/CT Imaging in Multiple MyelomaClinical Nuclear Medicine, 2017
- Metabolic Tumor Volume Assessed by 18F-FDG PET/CT for the Prediction of Outcome in Patients with Multiple MyelomaJournal of Nuclear Medicine, 2012
- Folate-Targeted Therapies for CancerJournal of Medicinal Chemistry, 2010
- Correlation of primary tumor prostate-specific membrane antigen expression with disease recurrence in prostate cancer.2003
- Tumor target prostate specific membrane antigen (PSMA) and its regulation in prostate cancerJournal of Cellular Biochemistry, 2003